Alterity Therapeutics has shown its Multiple System Atrophy drug ATH-434 has a potential market value of US$2.4 billion if ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback